Shuo Liang
- Co-authors
- Shuohui DongSonghan LiZhiqiang ChengGuangyong ZhangLinchuan LiSanyuan HuWenjie ZhangQian Xu
- Topics
- Pelvic floor disorders treatments (5 papers)Cancer, Hypoxia, and Metabolism (5 papers)Anorectal Disease Treatments and Outcomes (4 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Shuo Liang
27 papers receiving 621 citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Molecular Biology 333
- Cancer Research 184
- Oncology 132
- Surgery 87
- Epidemiology 65
Countries citing papers authored by Shuo Liang
This map shows the geographic impact of Shuo Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuo Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuo Liang more than expected).
Fields of papers citing papers by Shuo Liang
This network shows the impact of papers produced by Shuo Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuo Liang. The network helps show where Shuo Liang may publish in the future.
Co-authorship network of co-authors of Shuo Liang
This figure shows the co-authorship network connecting the top 25 collaborators of Shuo Liang. A scholar is included among the top collaborators of Shuo Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuo Liang. Shuo Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 9 | |
| 6 | 12 | |
| 7 | 5 | |
| 8 | ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancerbreakdown → | 297 |
| 9 | 13 | |
| 10 | 14 | |
| 11 | 5 | |
| 12 | 20 | |
| 13 | 9 | |
| 14 | 25 | |
| 15 | 35 | |
| 16 | 5 | |
| 17 | 35 | |
| 18 | 49 | |
| 19 | 3 | |
| 20 | 2 |
About Shuo Liang
Shuo Liang is a scholar working on Cancer Research, Biotechnology and Rheumatology, having authored 30 papers that have together received 623 indexed citations. Recurring topics across this work include Pelvic floor disorders treatments (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Anorectal Disease Treatments and Outcomes (4 papers). The work is most often cited by research in Cancer Research (184 citations), Molecular Biology (333 citations) and Oncology (132 citations). Shuo Liang has collaborated with scholars based in China and United States. Frequent co-authors include Shuohui Dong, Songhan Li, Zhiqiang Cheng, Guangyong Zhang, Linchuan Li, Sanyuan Hu, Wenjie Zhang, Qian Xu, Mingwei Zhong and Xiang Zhang. Their work appears in journals such as PLoS ONE, Journal of Ethnopharmacology and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.